| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000022158 |
| Receipt No. | R000025534 |
| Official scientific title of the study | The effect of sustained inflation in very low birth weight infants ventilated with high frequency oscillation: a randomized crossover trial. |
| Date of disclosure of the study information | 2016/05/01 |
| Last modified on | 2016/04/30 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The effect of sustained inflation in very low birth weight infants ventilated with high frequency oscillation: a randomized crossover trial. | |
| Title of the study (Brief title) | The effect of sustained inflation in preterm infants with high frequency oscillation: a randomized crossover trial. | |
| Region |
|
|
| Condition | ||
| Condition | Very low birth weight infants | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effect of sustained inflation combined with high frequency oscillation. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The ratio of desaturation(SpO2<80%) |
| Key secondary outcomes | Heart rate
Transcutaneous CO2 Cerebral and peripheral blood flow |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | No treatment |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | With Sustained Inflation(SI)and without SI.
6 hours later,we change with SI(or without SI), 30minutes of wash out time, we observe 6 hours. |
|
| Interventions/Control_2 | With Sustained Inflation(SI)and without SI.
6 hours later,we change with SI(or without SI), 30minutes of wash out time, we observe 6 hours. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Birth weight <1500g
(2)ventilated with HFO(Babylog VN500) (3)age>1 week after birth (4)No change of ventilator settings (MAP,Amplitude,VT,frequency) (5)agreement of their parents to participate in this study |
|||
| Key exclusion criteria | (1)unstable lung condition(i.e pneumonia, pneumothorax)
(2)a case that attending physician consider inappropriate |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Makoto Tamura |
| Organization | Takatsuki General Hospital |
| Division name | Department of Pediatrics and Neonatology |
| Address | 1-3-13 Kosobe, Takatsuki, Osaka 569-1192, Japan |
| TEL | 072-681-3801 |
| mako0803qoo@gmail.com | |
| Public contact | |
| Name of contact person | Makoto Tamura |
| Organization | Takatsuki General Hospital |
| Division name | Department of Pediatrics and Neonatology |
| Address | 1-3-13 Kosobe, Takatsuki, Osaka 569-1192, Japan |
| TEL | 072-681-3801 |
| Homepage URL | |
| mako0803qoo@gmail.com | |
| Sponsor | |
| Institute | Takatsuki General Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Takatsuki General Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | none |
| Other related organizations | |
| Co-sponsor | none |
| Name of secondary funder(s) | none |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 高槻病院(大阪府) Takatsuki General Hospital(Osaka, Japan) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025534 |